Related Experiment Videos

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer

Reo Maruyama1, Kimishige Akino, Minoru Toyota

  • 1First Department of Internal Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.

Carcinogenesis
|March 4, 2008
PubMed

Insights

Epigenetic silencing of Ras-association domain family 2A (RASSF2A) is frequent in gastric cancer. Restoring RASSF2A suppresses tumor growth and invasion, suggesting its role in tumorigenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Ras signaling pathways are frequently altered in gastric cancer, but the specific molecular mechanisms remain unclear.
  • Ras-association domain family (RASSF) genes, including RASSF2A, are implicated in tumor suppression.
  • Understanding the role of RASSF gene family members in gastric cancer is crucial for identifying novel therapeutic targets.

Purpose of the Study:

  • To investigate the expression profile of RASSF genes in gastric cancer.
  • To determine the role of RASSF2A in gastric cancer cell proliferation, apoptosis, and invasion.
  • To explore the clinical significance of RASSF2A epigenetic alterations in primary gastric tumors.

Main Methods:

  • Analysis of eight RASSF genes and MST1/2 expression in gastric cancer cell lines.
  • Assessment of RASSF2A promoter methylation and its effect on gene expression using 5-aza-2'-deoxycytidine treatment.
  • Functional studies involving RASSF2A introduction into gastric cancer cells to evaluate effects on colony formation and apoptosis.
  • Complementary DNA microarray analysis to identify RASSF2A-regulated genes.
  • Detection of RASSF2A aberrant methylation in primary gastric cancer tissues and correlation with clinical parameters.

Main Results:

  • RASSF2A was the most frequently downregulated gene among the studied RASSF family members in gastric cancer.
  • RASSF2A expression was silenced by promoter methylation in a significant subset of gastric cancer cell lines and primary tumors.
  • Reintroduction of RASSF2A suppressed colony formation, induced apoptosis, and altered cell morphology.
  • RASSF2A was found to suppress inflammatory cytokines, potentially inhibiting angiogenesis and invasion.
  • RASSF2A methylation correlated with favorable clinicopathological features, including absence of metastasis and less advanced stages.

Conclusions:

  • Epigenetic inactivation of RASSF2A through promoter methylation is a common event in gastric cancer.
  • RASSF2A acts as a tumor suppressor by inhibiting proliferation, promoting apoptosis, and reducing invasion.
  • Aberrant RASSF2A methylation is associated with specific molecular subtypes and less aggressive tumor characteristics.
  • RASSF2A represents a potential epigenetic biomarker and therapeutic target in a subset of gastric cancers.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...